# Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers

> **NCT01138748** · PHASE2 · TERMINATED · sponsor: **University Hospital, Ghent** · enrollment: 5 (actual)

## Conditions studied

- Inoperable Early Stage Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** hypofractionated radiation therapy

## Key facts

- **NCT ID:** NCT01138748
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2013-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01138748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01138748, "Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01138748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*